Grow Your Wealth
with Mutual Funds
SBI Healthcare Opportunities Fund-idcw
Equity
Mid Cap
Very High Risk
Latest AUM
₹ 4,063.6 Cr.
NAV as on 27 jul, 2026
₹ 318.78
+20.58%
3 years annulised
This Fund
Fund Details
Fund Names
SBI Healthcare Opportunities Fund-idcw
Inception Date
05 Jul 1999
Lock In
No Lock-in
Risk
Principal at very high risk
Category Average Annual Returns
6.04
Portfolio Composition Analysis
Equity
97.16%
Debt
0.06%
Cash
2.78%
Portfolio Updated on: 09 Jul, 2026
Sector Allocations
Equity
Debt
Healthcare
Materials
Portfolio Updated on: 27 jul, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.97% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.11% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.64% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.18% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.18% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.65% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.86% |
Debt & Credit Risk Analysis
| Alpha | 1.78% |
| Beta | 0.85% |
| Sharpe Ratio | 1.15% |
| Standard Deviation | 14.71% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 15.51% | NA | 6.12% |
| 6 Months | 25.29% | NA | 12.92% |
| 9 Months | 15.82% | NA | 4.47% |
| 1 Year | 14.64% | 14.64% | 6.04% |
| 2 Years | 33.29% | 15.45% | 24.93% |
| 3 Years | 84.05% | 22.55% | 25.71% |
| 5 Years | 119.43% | 17.02% | 19.91% |
| 7 Years | 361.04% | 24.40% | NA |
| 10 Years | 252.60% | 13.43% | 12.78% |
SBI Healthcare Opportunities Fund-idcw is one Equity mutual fund offered by SBI Mutual Fund. Launched on 05 Jul 1999, the fund aims Long term capital appreciation. Equity investments in stocks of companies in the healthcare sector. It manages assets worth ₹4,063.6 crore as on Tue Mar 31, 2026. The expense ratio stands at 1.93%.
Pradeep Kesavan has experience Prior to joining SBI MF, he has worked with Elara Capital, Accenture Strategy, Morgan Stanley and 3i Infotech
Tanmaya Desai has experience Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.
Top Performing Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +4.63% | +15.79% | +25.91% | +15.80% | +23.82% | +18.25% |
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +4.63% | +15.79% | +25.91% | +15.80% | +23.82% | +18.25% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw | 4,063.6 | +4.63% | +15.79% | +25.91% | +15.80% | +23.82% | +18.25% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw | 4,063.6 | +4.63% | +15.79% | +25.91% | +15.80% | +23.82% | +18.25% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +1.88% | +9.37% | +16.82% | +7.07% | +24.11% | +17.02% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +1.88% | +9.37% | +16.82% | +7.07% | +24.11% | +17.02% |
| SBI Healthcare Opportunities Fund-growth | 4,063.6 | +4.54% | +15.51% | +25.29% | +14.64% | +22.55% | +17.02% |
| Mirae Asset Healthcare Fund Direct-growth | 2,753.7 | +4.50% | +11.69% | +24.64% | +14.57% | +23.36% | +16.17% |
| Mirae Asset Healthcare Fund Direct-idcw | 2,753.7 | +4.50% | +11.69% | +24.64% | +14.57% | +23.36% | +16.17% |
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from SBI Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund-growth | 4,063.6 | +4.54% | +15.51% | +25.29% | +14.64% | +22.55% | +17.02% |
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +4.63% | +15.79% | +25.91% | +15.80% | +23.82% | +18.25% |
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +4.63% | +15.79% | +25.91% | +15.80% | +23.82% | +18.25% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw | 4,063.6 | +4.63% | +15.79% | +25.91% | +15.80% | +23.82% | +18.25% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw | 4,063.6 | +4.63% | +15.79% | +25.91% | +15.80% | +23.82% | +18.25% |
growth is based on 1-month returns of the funds
Top Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| Nippon India Pharma Fund-growth | 7,898.2 | +2.37% | +8.92% | +15.97% | +6.41% | +18.28% | +12.99% |
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| Nippon India Pharma Fund-idcw | 7,898.2 | +2.37% | +8.92% | +15.97% | +6.41% | +18.28% | +12.99% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +1.81% | +9.15% | +16.35% | +6.18% | +23.07% | +15.99% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +1.88% | +9.37% | +16.82% | +7.07% | +24.11% | +17.02% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +1.88% | +9.37% | +16.82% | +7.07% | +24.11% | +17.02% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | 6,293.1 | +1.81% | +9.15% | +16.35% | +6.18% | +23.07% | +15.99% |
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹585.48 | +23.82% | +18.25% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹585.48 | +23.82% | +18.25% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹406.78 | +23.82% | +18.25% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹406.78 | +23.82% | +18.25% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹47.15 | +24.11% | +17.02% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹28.47 | +24.11% | +17.02% | — |
| Sbi Healthcare Opportunities Fund-growth | ₹506.05 | +22.55% | +17.02% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹50.72 | +23.36% | +16.17% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹30.55 | +23.36% | +16.17% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 27 Jul 2026 | ₹318.78 |
| 24 Jul 2026 | ₹313.04 |
| 23 Jul 2026 | ₹314.30 |
| 22 Jul 2026 | ₹317.19 |
| 21 Jul 2026 | ₹320.55 |
| 20 Jul 2026 | ₹319.35 |
| 17 Jul 2026 | ₹316.27 |
| 16 Jul 2026 | ₹319.06 |
| 15 Jul 2026 | ₹318.06 |
| 14 Jul 2026 | ₹316.07 |
| 13 Jul 2026 | ₹314.41 |
| 10 Jul 2026 | ₹314.15 |
| 09 Jul 2026 | ₹312.93 |
| 08 Jul 2026 | ₹308.15 |
| 07 Jul 2026 | ₹310.94 |
| 06 Jul 2026 | ₹314.51 |
| 03 Jul 2026 | ₹315.67 |
| 02 Jul 2026 | ₹312.61 |
| 01 Jul 2026 | ₹309.68 |
| 30 Jun 2026 | ₹310.48 |
| 29 Jun 2026 | ₹308.50 |
| 25 Jun 2026 | ₹304.94 |
| 24 Jun 2026 | ₹305.46 |
| 23 Jun 2026 | ₹304.63 |
| 22 Jun 2026 | ₹302.73 |
| 19 Jun 2026 | ₹300.25 |
| 18 Jun 2026 | ₹298.26 |
| 17 Jun 2026 | ₹295.31 |
| 16 Jun 2026 | ₹295.17 |
| 12 Jun 2026 | ₹297.44 |
Portfolio Updated on: 28 Jul, 2026
Fund Growth & Size Analysis
+₹4,063.6 Cr
Since Launch
This Fund
Category Average
Compare Mutual funds
SBI Healthcare Opportunities Fund-idcw Returns Comparison
Compare SBI Healthcare Opportunities Fund-idcw with any MF,
EYF, stock or index
Jan 1, 2026 – Feb 1, 2026
SBI Healthcare Opportu....
No funds found for your search.
SBI Healthcare Opportunities Fund-idcw FAQ'S
- Sharpe Ratio: 1.15%
- Standard Deviation: 14.71%
- Beta: 0.85%
- Alpha: 1.78%
Additional important ratios:
As of Tue Mar 31, 2026, the total assets managed under SBI Healthcare Opportunities Fund-idcw stand at approximately ₹ 4,063.6 crore.
The SBI Healthcare Opportunities Fund-idcw has delivered the following short-term performance:
- 3 Months Return: 15.51%
- 6 Months Return: 25.29%
The historical growth of the SBI Healthcare Opportunities Fund-idcw is reflected through its CAGR returns:
- 3 Year CAGR: 22.55%
- 5 Year CAGR: 17.02%
- Return Since Launch: 16.70%
The portfolio of SBI Healthcare Opportunities Fund-idcw is distributed across different asset classes as follows:
- Equity: 97.16%
- Debt Instruments: 0.06%
- Other Assets: 2.78%
The SBI Healthcare Opportunities Fund-idcw is managed by Tanmaya Desai, representing SBI Mutual Fund.
The SBI Healthcare Opportunities Fund-idcw investments are allocated across market caps in the following manner:
- Large Cap Stocks: 1.00%
- Mid Cap Stocks: 1.00%
- Small Cap Stocks: 1.00%
Top stock holdings of SBI Healthcare Opportunities Fund-idcw include:
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.97% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.11% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.64% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.18% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.18% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.65% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.86% of the portfolio
Major sector exposures in SBI Healthcare Opportunities Fund-idcw are:
- Healthcare – accounts for 917.14% of the portfolio
- Materials – accounts for 29.95% of the portfolio
- Financial – accounts for 3.65% of the portfolio
